In addition, SHP2 is associated with the skewing of tumor-infiltrating T cells, particularly leukemia Tc1/Th1 cells, towards an inhibitory phenotype, suggesting its involvement in immune regulation within the TME [32]. This evidence concerns the gene PTPN11 and neoplasm.